Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for Atrium Therapeutics, Inc., €19k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Stephanie Kenney: trading record in brief
Stephanie Kenney discloses dealings in Atrium Therapeutics, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 20 April 2026 to 18 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 22 September 2026: a share grant of €19k, in Atrium Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephanie Kenney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,375 shares@ US$8.95Common StockSEC:0001193125-26-397948:0
30,000 shares0Common StockSEC:0001193125-26-170964:0
2 of 2 declarations
